Vaccine-associated paralytic poliomyelitis.

More on vaccine-associated paralytic poliomyelitis. N Engl J Med (1993) 0.75

Molecular evolution of the human enteroviruses: correlation of serotype with VP1 sequence and application to picornavirus classification. J Virol (1999) 7.79

Typing of human enteroviruses by partial sequencing of VP1. J Clin Microbiol (1999) 5.08

Deaths of children during an outbreak of hand, foot, and mouth disease in sarawak, malaysia: clinical and pathological characteristics of the disease. For the Outbreak Study Group. Clin Infect Dis (2000) 4.82

Molecular epidemiology and evolution of enterovirus 71 strains isolated from 1970 to 1998. J Virol (1999) 4.72

A population-based serologic survey of immunity to tetanus in the United States. N Engl J Med (1995) 4.21

Geographic distribution of wild poliovirus type 1 genotypes. Virology (1987) 4.03

Comparison of classic and molecular approaches for the identification of untypeable enteroviruses. J Clin Microbiol (2000) 3.99

Protease required for processing picornaviral coat protein resides in the viral replicase gene. J Virol (1979) 3.70

Enterovirus 71 infections and neurologic disease--United States, 1977-1991. J Infect Dis (1994) 3.31

Complete nucleotide sequence of enterovirus 71 is distinct from poliovirus. Virus Res (1995) 2.98

Preparation and characterization of encephalomyocarditis (EMC) virus. Methods Enzymol (1981) 2.81

Intramuscular injections within 30 days of immunization with oral poliovirus vaccine--a risk factor for vaccine-associated paralytic poliomyelitis. N Engl J Med (1995) 2.81

Current situation and control strategies for resurgence of diphtheria in newly independent states of the former Soviet Union. Lancet (1996) 2.78

Outbreak of paralytic poliomyelitis in Oman: evidence for widespread transmission among fully vaccinated children. Lancet (1991) 2.64

Epidemiology of poliomyelitis in the United States one decade after the last reported case of indigenous wild virus-associated disease. Clin Infect Dis (1992) 2.55

Detection and identification of vaccine-related polioviruses by the polymerase chain reaction. Virus Res (1991) 2.35

Trial of a supplemental dose of four poliovirus vaccines. N Engl J Med (2000) 2.35

Genotype-specific in vitro amplification of sequences of the wild type 3 polioviruses from Mexico and Guatemala. Virus Res (1992) 2.33

Protein processing map of poliovirus. J Virol (1984) 2.33

Immunogenicity of a supplemental dose of oral versus inactivated poliovirus vaccine. Lancet (1993) 2.24

Prolonged replication of a type 1 vaccine-derived poliovirus in an immunodeficient patient. J Clin Microbiol (1998) 2.24

Group-specific identification of polioviruses by PCR using primers containing mixed-base or deoxyinosine residue at positions of codon degeneracy. J Clin Microbiol (1996) 2.23

Duration of poliovirus excretion and its implications for acute flaccid paralysis surveillance: a review of the literature. J Infect Dis (1997) 2.16

Differential diagnosis of acute flaccid paralysis and its role in poliomyelitis surveillance. Epidemiol Rev (2000) 2.06

Stopping poliovirus vaccination after eradication: issues and challenges. Bull World Health Organ (2000) 2.00

Seroprevalence of antibody against poliovirus in inner-city preschool children. Implications for vaccination policy in the United States. JAMA (1996) 1.93

Changes in three of the four coat proteins of oral polio vaccine strain derived from type 1 poliovirus. J Virol (1980) 1.91

Failure to detect enterovirus in the spinal cord of ALS patients using a sensitive RT-PCR method. Neurology (2004) 1.83

Comparative study of five methods for intratypic differentiation of polioviruses. J Clin Microbiol (1995) 1.83

New-onset juvenile dermatomyositis: comparisons with a healthy cohort and children with juvenile rheumatoid arthritis. Arthritis Rheum (1997) 1.78

Picornaviral VPg sequences are contained in the replicase precursor. J Virol (1980) 1.77

Complete sequence of echovirus 23 and its relationship to echovirus 22 and other human enteroviruses. Virus Res (1998) 1.74

Molecular evolution of a type 1 wild-vaccine poliovirus recombinant during widespread circulation in China. J Virol (2000) 1.71

Poliomyelitis prevention in the United States. Updated recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2000) 1.67

Factors determining prevalence of maternal antibody to measles virus throughout infancy: a review. Clin Infect Dis (2000) 1.67

Cost-effectiveness of incorporating inactivated poliovirus vaccine into the routine childhood immunization schedule. JAMA (1996) 1.64

Molecular epidemiology and genetic diversity of echovirus type 30 (E30): genotypes correlate with temporal dynamics of E30 isolation. J Clin Microbiol (1999) 1.62

Molecular phylogeny of all human enterovirus serotypes based on comparison of sequences at the 5' end of the region encoding VP2. Virus Res (1998) 1.61

Echovirus 22 is an atypical enterovirus. J Virol (1990) 1.55

Persistence of vaccine-derived poliovirus following a mass vaccination campaign in Cuba: implications for stopping polio vaccination after global eradication. Int J Epidemiol (2001) 1.53

Reporting efficiency during a measles outbreak in New York City, 1991. Am J Public Health (1993) 1.53

Role of enterovirus 71 in acute flaccid paralysis after the eradication of poliovirus in Brazil. Emerg Infect Dis (1996) 1.47

Serotype-specific identification of enterovirus 71 by PCR. J Clin Virol (2000) 1.44

Outbreak of paralytic poliomyelitis in Albania, 1996: high attack rate among adults and apparent interruption of transmission following nationwide mass vaccination. Clin Infect Dis (1998) 1.38

Completeness of reporting for paralytic poliomyelitis, United States, 1980 through 1991. Implications for estimating the risk of vaccine-associated disease. Arch Pediatr Adolesc Med (1994) 1.23

Outbreaks of paralytic poliomyelitis, 1976-1995. J Infect Dis (1997) 1.20

Sabin monovalent oral polio vaccines: review of past experiences and their potential use after polio eradication. Clin Infect Dis (2001) 1.20

Multiple primer pairs for polymerase chain reaction (PCR) amplification of human parvovirus B19 DNA. J Virol Methods (1993) 1.19

Disease eradication as a public health strategy: a case study of poliomyelitis eradication. Bull World Health Organ (2000) 1.18

Echovirus 30 infection and aseptic meningitis in parents of children attending a child care center. J Infect Dis (1994) 1.15

Measles eradication: is it in our future? Am J Public Health (2000) 1.12

Paralytic poliomyelitis in Romania, 1984-1992. Evidence for a high risk of vaccine-associated disease and reintroduction of wild-virus infection. Am J Epidemiol (1994) 1.09

Tetanus surveillance--United States, 1989-1990. MMWR CDC Surveill Summ (1992) 1.09

Juvenile dermatomyositis at diagnosis: clinical characteristics of 79 children. J Rheumatol (1998) 1.07

A molecular and serologic evaluation of enteroviral involvement in human myocarditis. J Mol Cell Cardiol (1990) 1.05

Oligonucleotide probes for the specific detection of the wild poliovirus types 1 and 3 endemic to Brazil. Intervirology (1991) 1.04

Specific detection of echoviruses 22 and 23 in cell culture supernatants by RT-PCR. J Med Virol (1999) 1.02

Paralytic poliomyelitis in Oman: association between regional differences in attack rate and variations in antibody responses to oral poliovirus vaccine. Int J Epidemiol (1993) 1.01

Prevention of secondary transmission of pertussis in households with early use of erythromycin. Am J Dis Child (1992) 1.01

Vaccine-associated paralytic poliomyelitis and HIV infection. Lancet (1994) 1.00

High degree of genetic diversity of non-polio enteroviruses identified in Georgia by environmental and clinical surveillance, 2002-2005. J Med Microbiol (2010) 0.99

Acute hemorrhagic conjunctivitis due to enterovirus 70 in American Samoa: serum-neutralizing antibodies and sex-specific protection. Am J Epidemiol (1992) 0.96

Defining surrogate serologic tests with respect to predicting protective vaccine efficacy: poliovirus vaccination. Ann N Y Acad Sci (1995) 0.96

Distribution of wild type 1 poliovirus genotypes in China. J Infect Dis (1993) 0.96

Concurrent outbreaks of pertussis and Mycoplasma pneumoniae infection: clinical and epidemiological characteristics of illnesses manifested by cough. Clin Infect Dis (1995) 0.95

Pathologic studies of fatal cases in outbreak of hand, foot, and mouth disease, Taiwan. Emerg Infect Dis (2001) 0.95

Oseltamivir-resistant 2009-2010 pandemic influenza A (H1N1) in an immunocompromised patient. Clin Microbiol Infect (2010) 0.95

Type-specific detection of echovirus 30 isolates using degenerate reverse transcriptase PCR primers. J Clin Microbiol (2001) 0.94

Outbreak of paralytic poliomyelitis in a highly immunized population in Jordan. J Infect Dis (1997) 0.93

Geographical genotypes (geotypes) of poliovirus case isolates from the former Soviet Union: relatedness to other known poliovirus genotypes. J Gen Virol (1995) 0.93

Chronic group A coxsackievirus infection in agammaglobulinemia: demonstration of genomic variation of serotypically identical isolates persistently excreted by the same patient. J Infect Dis (1988) 0.93

An outbreak of acute haemorrhagic conjunctivitis in Melaka, Malaysia. Singapore Med J (2003) 0.93

Sites other than nucleotide 234 determine cardiovirulence in natural isolates of coxsackievirus B3. J Med Virol (1997) 0.93

A study evaluating poliovirus antibodies and risk factors associated with polio seropositivity in low socioeconomic areas of Pakistan. Vaccine (2013) 0.90

Tetanus surveillance--United States, 1991-1994. MMWR CDC Surveill Summ (1997) 0.89

Surgical management of necrotizing Candida esophagitis. Ann Thorac Surg (1999) 0.89

Vaccine-preventable disease susceptibility in a young adult Micronesian population. Southeast Asian J Trop Med Public Health (1994) 0.88

A theoretical framework for evaluating the sensitivity of surveillance for detecting wild poliovirus: II. Factors affecting detection sensitivity in a population with circulating wild poliovirus. J Infect Dis (1997) 0.86

Serologic evidence of an association between enteroviruses and the onset of type 1 diabetes mellitus. Pittsburgh Diabetes Research Group. J Infect Dis (1995) 0.85

Outbreak of poliomyelitis in Gizan, Saudi Arabia: cocirculation of wild type 1 polioviruses from three separate origins. J Infect Dis (1997) 0.83

Coxsackievirus B3 clinical isolates and murine myocarditis. Virus Res (1996) 0.83

The role of enteroviral infections in the development of IDDM: limitations of current approaches. Diabetes (1997) 0.82

An epidemic of acute hemorrhagic conjunctivitis in American Samoa caused by coxsackievirus A24 variant. Am J Epidemiol (1989) 0.82

Evaluation of a single dose of diphtheria toxoid among adults in the Republic of Georgia, 1995: immunogenicity and adverse reactions. J Infect Dis (2000) 0.82

Commentary: the unfolding story of global poliomyelitis eradication. J Infect Dis (1997) 0.82

Using cost-effectiveness analysis to evaluate targeting strategies: the case of vitamin A supplementation. Health Policy Plan (1997) 0.82

The complete genome sequence for an American isolate of enterovirus 77. Arch Virol (2007) 0.81

Immunogenicity of tetravalent rhesus rotavirus vaccine administered with buffer and oral polio vaccine. Am J Dis Child (1991) 0.81

Status of poliomyelitis eradication in Europe and the Central Asian republics of the former Soviet Union. J Infect Dis (1997) 0.81

Coxsackievirus B2 infection and aseptic meningitis: a focal outbreak among members of a high school football team. J Infect Dis (1993) 0.80

Widespread paralytic poliomyelitis in Pakistan: A case-control study to determine risk factors and implications for poliomyelitis eradication. J Infect Dis (2000) 0.80

Comparison of a monoclonal antibody-based IgM capture ELISA with a neutralization assay for assessing response to trivalent oral poliovirus vaccine. J Infect Dis (1997) 0.80

Sequential and combined use of inactivated and oral poliovirus vaccines: Dolj District, Romania, 1992-1994. J Infect Dis (1997) 0.80

Surveillance during an era of rapidly changing poliovirus epidemiology in India: the role of one vs. two stool specimens in poliovirus detection, 2000-2010. Epidemiol Infect (2013) 0.80

Increased immunogenicity of oral poliovirus vaccine administered in mass vaccination campaigns compared with the routine vaccination program in Jordan. J Infect Dis (1997) 0.79